Legal Representation
Attorney
Donna J. Bunton
USPTO Deadlines
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 3, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 2, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 3, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 2, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 2, 2022 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| May 26, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 26, 2022 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Nov 25, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 23, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 23, 2021 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Nov 23, 2021 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| May 28, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 26, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 26, 2021 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| May 26, 2021 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Nov 27, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 25, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 25, 2020 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Nov 25, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 28, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 26, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 26, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 26, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 26, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 9, 2019 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Oct 1, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 1, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 11, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 29, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 28, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 27, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 11, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS
First Use Anywhere:
Jun 5, 1995
First Use in Commerce:
Jun 5, 1995
Classification
International Classes
005
042